Incyte Corporation
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
Last updated:
Abstract:
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
4 May 2021
Issue date:
24 Mar 2022